(Q36303867)

13 August 2017

1 reference

title

Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors (English)

1 reference

13 August 2017

Carolyn I Sartor

1

1 reference

13 August 2017

publication date

1 December 2004

1 reference

Nature Clinical Practice Oncology

13 August 2017

published in

1 reference

13 August 2017

volume

1

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

80-87

1 reference

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Correlation of epidermal growth factor receptor and radiosensitivity in human maxillary carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced ce

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

DNA damage checkpoint control in cells exposed to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Induction of apoptosis by ionizing radiation and CI-1033 in HuCCT-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

DNA double-strand breaks: signaling, repair and the cancer connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Tying loose ends: roles of Ku and DNA-dependent protein kinase in the repair of double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

MAPK pathways in radiation responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Antiproliferative, antiangiogenic and proapoptotic activity of h-R3: A humanized anti-EGFR antibody

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Tumor response to radiotherapy regulated by endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0048

7 January 2021

Identifiers

DOI

10.1038/NCPONC0048

1 reference

13 August 2017

1 reference